UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (right to buy) | Â (1)(2) | 01/30/2022 | Common Stock | 938 | $ 36.36 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 04/30/2022 | Common Stock | 1,668 | $ 36.47 | D | Â |
Stock Option (right to buy) | Â (2)(3) | 07/30/2022 | Common Stock | 1,668 | $ 34.7 | D | Â |
Stock Option (right to buy) | Â (2)(4) | 10/31/2022 | Common Stock | 1,668 | $ 36.68 | D | Â |
Stock Option (right to buy) | Â (2)(5) | 12/17/2022 | Common Stock | 2,500 | $ 40.22 | D | Â |
Stock Option (right to buy) | Â (2)(6) | 01/28/2023 | Common Stock | 3,336 | $ 49.48 | D | Â |
Stock Option (right to buy) | Â (2)(7) | 04/29/2023 | Common Stock | 3,752 | $ 59.23 | D | Â |
Stock Option (right to buy) | Â (2)(8) | 07/29/2023 | Common Stock | 3,752 | $ 71.33 | D | Â |
Stock Option (right to buy) | Â (2)(9) | 10/28/2023 | Common Stock | 3,752 | $ 78.11 | D | Â |
Stock Option (right to buy) | Â (2)(10) | 12/02/2023 | Common Stock | 3,752 | $ 81.56 | D | Â |
Stock Option (right to buy) | Â (2)(11) | 02/03/2024 | Common Stock | 5,626 | $ 74.3 | D | Â |
Stock Option (right to buy) | Â (2)(12) | 07/28/2024 | Common Stock | 3,750 | $ 87.64 | D | Â |
Stock Option (right to buy) | Â (2)(13) | 10/27/2024 | Common Stock | 1,875 | $ 103.1 | D | Â |
Stock Option (right to buy) | Â (2)(14) | 12/19/2024 | Common Stock | 5,000 | $ 117.18 | D | Â |
Stock Option (right to buy) | Â (2)(15) | 02/02/2025 | Common Stock | 2,500 | $ 118.57 | D | Â |
Stock Option (right to buy) | Â (2)(16) | 05/04/2025 | Common Stock | 3,125 | $ 109.9 | D | Â |
Stock Option (right to buy) | Â (2)(17) | 07/27/2025 | Common Stock | 3,125 | $ 132.56 | D | Â |
Stock Option (right to buy) | Â (2)(18) | 11/09/2025 | Common Stock | 3,125 | $ 114.08 | D | Â |
Stock Option (right to buy) | Â (2)(19) | 02/01/2026 | Common Stock | 3,125 | $ 100.8 | D | Â |
Stock Option (right to buy) | Â (2)(20) | 05/02/2026 | Common Stock | 5,000 | $ 104.97 | D | Â |
Restricted Stock Unit | Â (21) | Â (21) | Common Stock | 1,880 | $ (22) (23) | D | Â |
Restricted Stock Unit | Â (24) | Â (24) | Common Stock | 2,500 | $ (22) (23) | D | Â |
Restricted Stock Unit | Â (25) | Â (25) | Common Stock | 1,250 | $ (22) (23) | D | Â |
Restricted Stock Unit | Â (26) | Â (26) | Common Stock | 3,125 | $ (22) (23) | D | Â |
Restricted Stock Unit | Â (27) | Â (27) | Common Stock | 2,700 | $ (22) (23) | D | Â |
Restricted Stock Unit | Â (28) | Â (28) | Common Stock | 2,500 | $ (22) (23) | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
PEHL MICHAEL F. C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT, NJ 07901 |
 |  |  See remarks |  |
/s/ Michael F. Pehl __________________________________________ Michael F. Pehl | 06/24/2016 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The option is immediately exercisable and is fully vested. |
(2) | The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). |
(3) | The option is immediately exercisable and will vest on July 30, 2016. |
(4) | The option is immediately exercisable and will vest on October 31, 2016. |
(5) | The option is immediately exercisable and will vest on December 17, 2016. |
(6) | The option is immediately exercisable and will fully vest on January 28, 2017. |
(7) | The option is immediately exercisable and will fully vest on April 29, 2017. |
(8) | The option is immediately exercisable and will vest in two annual installments as follows: 1,876 shares on July 29, 2016; 1,876 shares on July 29, 2017. |
(9) | The option is immediately exercisable and will vest in two annual installments as follows: 1,876 shares on October 28, 2016; 1,876 shares on October 28, 2017. |
(10) | The option is immediately exercisable and will vest in two annual installments as follows: 1,876 shares on December 2, 2016; 1,876 shares on December 2, 2017. |
(11) | The option is immediately exercisable and will vest in two annual installments as follows: 1,876 shares on February 3, 2017; 1,876 shares on February 3, 2018. |
(12) | The option is immediately exercisable and will vest in three annual installments as follows: 1,250 shares on July 28, 2016; 1,250 shares on July 28, 2017; 1,250 shares on July 28, 2018. |
(13) | The option is immediately exercisable and will vest in three annual installments as follows: 625 shares on October 27, 2016; 625 shares on October 27, 2017; 625 shares on October 27, 2017. |
(14) | The option is immediately exercisable and will vest in four equal annual installments commencing on December 19, 2015. |
(15) | The option is immediately exercisable and will vest in four equal annual installments commencing on February 2, 2016. |
(16) | The option is immediately exercisable and will vest in four equal annual installments commencing on May 4, 2016. |
(17) | The option is immediately exercisable and will vest in four equal annual installments commencing on July 27, 2016. |
(18) | The option is immediately exercisable and will vest in four equal annual installments commencing on November 9, 2016. |
(19) | The option is immediately exercisable and will vest in four equal annual installments commencing on February 1, 2017. |
(20) | The option is immediately exercisable and will vest in four equal annual installments commencing on May 2, 2017. |
(21) | The restricted stock units will vest on December 2, 2016. Vested shares will be delivered to the reporting person promptly after the vesting date. |
(22) | The restricted stock unit was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). |
(23) | Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. |
(24) | The restricted stock units will vest on July 28, 2017. Vested shares will be delivered to the reporting person on the vesting date. |
(25) | The restricted stock units will vest on December 19, 2017. Vested shares will be delivered to the reporting person on the vesting date. |
(26) | The restricted stock units will vest on May 4, 2018. Vested shares will be delivered to the reporting person on the vesting date. |
(27) | The restricted stock units will vest on December 16, 2018. Vested shares will be delivered to the reporting person on the vesting date. |
(28) | The restricted stock units will vest on May 2, 2019. Vested shares will be delivered to the reporting person on the vesting date. |
 Remarks: President Hematology & Oncology |